Therapeutic Antibodies: New Trends in Discovery, Developability and Characterization

A special issue of Antibodies (ISSN 2073-4468).

Deadline for manuscript submissions: 21 March 2025 | Viewed by 257

Special Issue Editors

NMI, Natural and Medical Sciences Institute at the University of Tuebingen, 72770 Reutlingen, Germany
Interests: epitope mapping; developability assessment; mode-of-action elucidation; new analytical techniques base on mass spectrometry

E-Mail Website
Guest Editor
Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA
Interests: immunology; antibodies; vaccines; epitope mapping; structural biology

Special Issue Information

Dear Colleagues,

The development of therapeutic antibodies has continued its success story in recent years. Every year, around a dozen antibodies are approved by regulatory authorities in the US and EU for the treatment of cancer or other diseases, such as autoimmune diseases. The development pipelines of research-based pharmaceutical companies are well filled. However, there are new trends in the techniques used to discover suitable antibody candidates and test their developability and modes of action. First and foremost is the integration of artificial intelligence and machine learning tools to generate antibodies with tailored properties and predict their developability. High-throughput screening technologies enable researchers to identify the best candidates to take to the next stage of development and use to manipulate biological molecules. High-resolution analytical methods such as affinity chromatography with mass spectrometric detection enable the highly detailed investigation of binding selectivity and a better understanding of the mechanisms of action, thereby building a basis for rational antibody engineering. Highly sensitive analytical techniques such as mass spectrometry-based analysis of host–cell proteins will aid in cell culture development and contribute to a better assessment of drug safety. Lastly, new antibody formats and engineered variants will provide new or improved functionalities.

This Special Issue on therapeutic antibody discovery, development, and characterization will present new technology developments and applications in the field. Researchers will present their latest results, and review articles will cover new developments.

Dr. Anne Zeck
Dr. David J Vance
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibodies is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antibody lead candidates selection
  • epitope prediction and mapping
  • developability assessment
  • antibody engineering
  • mode-of-action elucidation
  • host–cell analysis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop